Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

Kathryn S. Hensley; Marlou J. Jongkees; Daryl Geers; Corine H. GeurtsvanKessel; Yvonne M. Mueller; Virgil A. S. H. Dalm; Grigorios Papageorgiou; Hanka Steggink; Alicja Górska; Susanne Bogers; Jan G. den Hollander; Wouter F.W. Bierman; L. B. S. Gelinck; Emile F. Schippers; Heidi Ammerlaan; Marc van der Valk; Marit G. A. van Vonderen; Corine Delsing; Elisabeth H. Gisolf; Anke H. W. Bruns; Fanny N. Lauw; Marvin A. H. Berrevoets; Kim Sigaloff; Robert Soetekouw; Judith Branger; Quirijn de Mast; Adriana J. J. Lammers; Selwyn H. Lowe; Rory D. de Vries; Peter D. Katsikis; Bart Rijnders; Kees Brinkman; Anna H.E. Roukens; Casper Rokx

doi:10.1371/journal.pmed.1003979

Key Points

To assess the immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV.
Nationwide prospective cohort study conducted in the Netherlands.
Trial registered in the Netherlands Trial Register under identifier NL9214.
Vaccine reactogenicity profiles and humoral immunogenicity outcomes were monitored prospectively in vaccinated individuals living with HIV.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Prospective cohort study evaluates immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV, highlighting safety and immune responses.

Abstract

The trial was registered in the Netherlands Trial Register (NL9214). https://www.trialregister.nl/trial/9214.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hensley et al. (2022) studied this question.

synapsesocial.com/papers/69db1d991e19c8ae08836504 https://doi.org/10.1371/journal.pmed.1003979

View Full Paper

Ask AI

Bookmark

Share

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading